医学
黄斑变性
血管抑制剂
随机对照试验
眼科
生物仿制药
贝伐单抗
内科学
化疗
作者
Jan Hamouz,Agnieszka Nowosielska,Anna Święch-Zubilewicz,Santiago Abengoechea,Kristīne Baumane,Attila Vajas,Małgorzata Siewierska,Milan Veselovsky,Miroslav Veith,Ágnes Kerényi,Shobhana Mange,Krishnapada Baidya,Guna Laganovska,Ignasi Jürgens,András Papp,Jignesh Gosai,Jana Štefaničková,Mei Han,Piotr Fryczkowski,Dominik Zalewski,Jing Wang,Wenbin Wei
标识
DOI:10.1016/j.oret.2024.10.001
摘要
This study aimed to demonstrate the clinical equivalence of biosimilar QL1205 and reference ranibizumab, Lucentis®, in patients with neovascular age-related macular degeneration (nAMD).
科研通智能强力驱动
Strongly Powered by AbleSci AI